Nonadherence in tuberculosis treatment: Predictors and consequences in New York City

American Journal of Medicine

Volumn 102, Issue 2, 1997, Pages 164-170

  Pablos Méndez, Ariel ^a,b,d   Knirsch, Charles A ^a   Barr, R Graham ^a   Lerner, Barron H ^b   Frieden, Thomas R ^a,b,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Centers for Dis Contr and Prev ^*  (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d MPH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ARTICLE; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG COST; DRUG USE; FEMALE; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; SEROCONVERSION; SPUTUM CULTURE; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HOMELESS PERSONS; HUMANS; INCOME; INFANT; MALE; MIDDLE AGED; NEW YORK CITY; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TUBERCULOSIS; URBAN HEALTH;

EID: 18544411711     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00402-0     Document Type: Article

References (51)

1. Raviglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 1995;273:220-226.
2. Bloch AB, Reider HL, Kelly GD, et al. The epidemiology of tuberculosis in the United States: implications for diagnosis and treatment. Clin Chest Med. 1989;10:297-313.
3. Jereb JA, Kelly GD, Dooley SW, et al. Tuberculosis morbidity in the United States: final data, 1990. MMWR. 1992;40(SS-3):23-27.
4. Centers for Disease Control. Tuberculosis Statistics: States and Cities, 1985. DHHS publication no 87-8249. Washington, DC: Washington Printing Office; 1986.
5. New York City Department of Health. Tuberculosis in New York City, 1990: Information Survey. New York: New York City Department of Health; 1991.
6. Barnes PF, Barrows SA. Tuberculosis in the 1990's. Ann Intern Med. 1993;119:400-410.
7. Drucker E, Alcabes P, Bosworth W, Sckell B. Childhood tuberculosis in the Bronx, New York. Lancet. 1994;343:1482-1485.
8. Cantwell MF, Snider DE, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA. 1994;272:535-539.
9. Brudney K, Dobkin J. A tale of two cities: tuberculosis control in Nicaragua and New York City. Sem Respir Infect. 1991;6:261-272.
10. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144;745-749.
11. Fox W. The problem of self-administration of drugs, with particular reference to pulmonary tuberculosis. Tubercle. 1958;39:269-274.
12. Tuberculosis chemotherapy centre, Madras. A concurrent comparison of intermittent (twice weekly) isoniazid plus streptomycin and daily isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis. Bull WHO. 1964;31:247-271.
13. Moodie AS. Mass ambulatory chemotherapy in the treatment of tuberculosis in a predominantly urban community. Am Rev Respir Dis. 1967;95:384-397.
14. Moulding T. New responsibilities for health departments and public health nurses in tuberculosis: keeping the outpatient on therapy. Am J Pub Health. 1966;56:416-427.
15. Bayer R, Wilkinson D. Directly observed therapy: history of an idea. Lancet. 1995;345:1545-1548.
16. Frieden TR, Sterling T, Pablos-Méndez A, et al. The emergence of drug-resistant tuberculosis in New York City. NEJM. 1993;328:521-526.
17. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA. 1994;271:665-671.
18. Bifani PJ, Plikaytis BB, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant Mycibacterium tuberculosis lone family. JAMA. 1996;275:452-457.
19. Addington WW. Patient compliance: the most serious remaining problem in control of tuberculosis in the US. Chest. 1979;76(suppl 6):741-743.
20. Ferrer X, Kirschbaum A, Toro J, et al. Compliance with tuberculosis treatment in adults in Santiago, Chile. Boletín de la Oficina Sanitaria Panamericana. 1991;111:423-431.
21. Crespo R, Valdes L, Bobe I, Cayla JA. Difficulties in carrying out the treatment as seen by the tuberculous patient. Atención Primaria. 1992;9:260-262.
22. Sumartojo E. When tuberculosis treatment fails. Am Rev Respir Dis. 1993;147:1311-1320.
23. Ormerod LP, Prescott RJ. Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respir Med. 1991;85:239-242.
24. WHO Tuberculosis Programme. Framework for Effective Tuberculosis Control. Geneva, Switzerland: WHO/TB/94, 179: 1994.
25. Stampfer MJ, Willet WC, Speizer FE. Test of the national death index. Am J Epidemiol. 1984;119:837-839.
26. Dean AG, Dean JA, Coulombier D, et al. Epi Info, Version 6. Atlanta, Georgia: Centers for Disease Control and Prevention: and Geneva, Switzerland: World Health Organization; 1994.
27. Norusis MJ. SPSS for Windows: Advanced Statistics, Release 6.0. Chicago, Illinois: SPSS Inc.; 1993.
28. Hosmer DW, Lemeshow SL. Applied Logistic Regression. New York: Wiley & Sons; 1989.
29. Pablos-Méndez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA. 1996;276:1223-1228.
30. Kim SJ, Hong YP. Drug resistance of Mycobacterium tuberculosis in Korea. Tuber Lung Dis. 1992;73:219-224.
31. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. NEJM. 1994;330:1179-1184.
32. Melnikow J, Kiefe C. Patient compliance and medical research: issues in methodology. J Gen Intern Med. 1994;9:96-105.
33. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Pub Health. 1992;92:703-710.
34. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Maryland: Johns Hopkins University Press; 1979.
35. Stephenson BJ, Rowe BH, Haynes RB, et al. Is this patient taking the treatment as prescribed? JAMA. 1993;269:2779-2781.
36. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. JAMA. 1993;270:65-68.
37. Morisky DE, Malotte CK, Choi P, et al. A patient education program to improve adherence rates with antituberculosis drug regimens. Health Educ Q. 1990;17:253-267.
38. Barnwell MD, Chitkara R, Lamberta F. Tuberculosis prevention project. J Natl Med Assoc. 1992;84:1014-1018.
39. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City-turning the tide. NEJM. 1995;333:229-233.
40. China Tuberculosis Control Collaboration. Results of directly observed short course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet. 1996;347:358-362.
41. Approaches to improving adherence to antituberculosis therapy-South Carolina and New York, 1986-1991. MMWR. 1993;42:74-75.
42. Centers for Disease Control and Prevention. Tuberculosis control laws -United States, 1993: recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET). MMWR. 1993;42 (No. RR-15):1-13.
43. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA. 1995;274:945-951.
44. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis. We can't afford not to do it. NEJM. 1993;328:576-578.
45. Murray CJ, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull IUATLD. 1990;65:6-64.
46. Division of Tuberculosis Elimination, National Center for HIV, STD and TB Prevention (proposed), CDC. Tuberculosis morbidity - United States, 1995. MMWR. 1996;45(18):365-370.
47. Dubler NN, et al. Tuberculosis in the 1990s: ethical, legal, and public policy issues in screening, treatment, and the protection of those in congregate facilities. In: The Tuberculosis Revival - Individual Rights and Societal Obligation in a Time of AIDS. New York: United Hospital Fund; 1992:1-21.
48. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med. 1994;149:1359-1374.
49. Annas GJ. Control of tuberculosis: the law and the public health. NEJM. 1993;328:585-588.
50. Gostin L. Controlling the re-emergent tuberculosis epidemic: a fifty-state survey of TB statues and proposals for reform. JAMA. 1993;269:255-261.
51. Lerner BH. Temporarily detained: tuberculous alcoholics in Seattle, 1949 through 1960. Am J Pub Health. 1996;86:257-265.